FDA Risk Evaluation and Mitigation Strategy Explained in Webinar

Posted on

The Food and Drug Administration will be holding a webinar tomorrow designed to educate interested parties on how a Risk Evaluation and Mitigation Strategy works and what such a measure means for the medical community.  In the meantime, the organization is also explaining why an REMS is so important.  Basically, prior to the approval of a medication by the FDA, manufacturers are required to prove to the agency that the benefits of a drug are going to outweigh the risks that the drug poses to users.  The information is also used to help doctors figure out how to prescribe a given medication, essentially determining what the best methods of administration might be.

Click here to learn more about the webinar.